Vitalhub Corp. (TSE:VHI – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is C$14.33.
VHI has been the subject of several research reports. Royal Bank Of Canada cut their price objective on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research report on Monday, January 26th. Scotiabank dropped their price target on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th.
Get Our Latest Report on Vitalhub
Insider Transactions at Vitalhub
Vitalhub Stock Performance
TSE VHI opened at C$8.17 on Friday. The stock has a market cap of C$515.70 million, a PE ratio of 204.25, a P/E/G ratio of 1.18 and a beta of 0.83. The firm has a 50-day moving average of C$8.64 and a 200-day moving average of C$10.03. Vitalhub has a 52-week low of C$7.63 and a 52-week high of C$14.64.
Vitalhub Company Profile
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Read More
- Five stocks we like better than Vitalhub
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
